PURPOSE: Physical activity may reduce many side effects of cancer treatment and may improve survival. The purpose of this analysis was to compare physical activity in cancer patients and survivors to those who have never had cancer and examine changes between 2005-2006 and 2009-2010. METHODS: Data were extracted from the 2005-2006 and 2009-2010 Canadian Community Health Survey. Respondents were asked whether they currently have or had cancer in the past and about physical activity. Based on duration and type of reported activity, respondents were classified as inactive, moderately active, or active. Logistic regression was used to assess the relationship between cancer history and physical activity. Differences in physical activity by survey cycle according to cancer status were also examined. RESULTS: After adjustment, respondents with cancer were more likely to be inactive than those who had never had cancer (OR = 1.39, 95 % CI 1.21-1.58, inactive vs. active), while individuals with previous cancer did not differ from population levels. The odds of being moderately active or inactive did not vary over time in those with current or previous cancer; however, respondents who had never had cancer were less likely to be moderately active or inactive in 2009-2010 (OR = 0.94, 95 % CI 0.92-0.96, inactive vs. active). CONCLUSIONS: Individuals with cancer are less likely to be active than those who have never had cancer, but those with a history of cancer have similar physical activity levels to population levels. Activity levels in all three groups are much lower than recommended. IMPLICATIONS FOR CANCER SURVIVORS: It is encouraging to note that those with cancer history are not less likely than the general population to be physically active. Individuals with a history of cancer have much to gain from participation in physical activity and health care providers should continue to encourage physical activity in accordance with published guidelines.
PURPOSE: Physical activity may reduce many side effects of cancer treatment and may improve survival. The purpose of this analysis was to compare physical activity in cancerpatients and survivors to those who have never had cancer and examine changes between 2005-2006 and 2009-2010. METHODS: Data were extracted from the 2005-2006 and 2009-2010 Canadian Community Health Survey. Respondents were asked whether they currently have or had cancer in the past and about physical activity. Based on duration and type of reported activity, respondents were classified as inactive, moderately active, or active. Logistic regression was used to assess the relationship between cancer history and physical activity. Differences in physical activity by survey cycle according to cancer status were also examined. RESULTS: After adjustment, respondents with cancer were more likely to be inactive than those who had never had cancer (OR = 1.39, 95 % CI 1.21-1.58, inactive vs. active), while individuals with previous cancer did not differ from population levels. The odds of being moderately active or inactive did not vary over time in those with current or previous cancer; however, respondents who had never had cancer were less likely to be moderately active or inactive in 2009-2010 (OR = 0.94, 95 % CI 0.92-0.96, inactive vs. active). CONCLUSIONS: Individuals with cancer are less likely to be active than those who have never had cancer, but those with a history of cancer have similar physical activity levels to population levels. Activity levels in all three groups are much lower than recommended. IMPLICATIONS FOR CANCER SURVIVORS: It is encouraging to note that those with cancer history are not less likely than the general population to be physically active. Individuals with a history of cancer have much to gain from participation in physical activity and health care providers should continue to encourage physical activity in accordance with published guidelines.
Authors: Darren Er Warburton; Sarah Charlesworth; Adam Ivey; Lindsay Nettlefold; Shannon Sd Bredin Journal: Int J Behav Nutr Phys Act Date: 2010-05-11 Impact factor: 6.457
Authors: Cheryl L Rock; Colleen Doyle; Wendy Demark-Wahnefried; Jeffrey Meyerhardt; Kerry S Courneya; Anna L Schwartz; Elisa V Bandera; Kathryn K Hamilton; Barbara Grant; Marji McCullough; Tim Byers; Ted Gansler Journal: CA Cancer J Clin Date: 2012-04-26 Impact factor: 508.702
Authors: Vivian E von Gruenigen; Heidi E Frasure; Mary Beth Kavanagh; Edith Lerner; Steven E Waggoner; Kerry S Courneya Journal: Gynecol Oncol Date: 2011-05-19 Impact factor: 5.482
Authors: M Carayol; P Bernard; J Boiché; F Riou; B Mercier; F Cousson-Gélie; A J Romain; C Delpierre; G Ninot Journal: Ann Oncol Date: 2012-10-05 Impact factor: 32.976
Authors: Jean K Brown; Tim Byers; Colleen Doyle; Kerry S Coumeya; Wendy Demark-Wahnefried; Lawrence H Kushi; Anne McTieman; Cheryl L Rock; Noreen Aziz; Abby S Bloch; Barbara Eldridge; Kathryn Hamilton; Carolyn Katzin; Amy Koonce; Julie Main; Connie Mobley; Marion E Morra; Margaret S Pierce; Kimberly Andrews Sawyer Journal: CA Cancer J Clin Date: 2003 Sep-Oct Impact factor: 508.702
Authors: Wendy Demark-Wahnefried; Elizabeth C Clipp; Isaac M Lipkus; David Lobach; Denise Clutter Snyder; Richard Sloane; Bercedis Peterson; Jennifer M Macri; Cheryl L Rock; Colleen M McBride; William E Kraus Journal: J Clin Oncol Date: 2007-07-01 Impact factor: 44.544
Authors: Erin L McGowan; Daniel Fuller; Nicoleta Cutumisu; Scott North; Kerry S Courneya Journal: Support Care Cancer Date: 2017-06-27 Impact factor: 3.603
Authors: F Hausmann; V V Iversen; M Kristoffersen; H Gundersen; E Johannsson; M Vika Journal: Support Care Cancer Date: 2018-04-14 Impact factor: 3.603
Authors: M D J Wolvers; J B J Bussmann; F Z Bruggeman-Everts; S T Boerema; R van de Schoot; M M R Vollenbroek-Hutten Journal: Int J Behav Med Date: 2018-02
Authors: Sophia Y Liu; Lin Lu; Dan Pringle; Mary Mahler; Chongya Niu; Rebecca Charow; Kyoko Tiessen; Christine Lam; Oleksandr Halytskyy; Hiten Naik; Henrique Hon; Margaret Irwin; Vivien Pat; Christina Gonos; Catherine W T Chan; Jodie Villeneuve; Ravi M Shani; Maha Chaudhry; M Catherine Brown; Peter Selby; Doris Howell; Wei Xu; Shabbir M H Alibhai; Jennifer M Jones; Geoffrey Liu; Lawson Eng Journal: Cancer Med Date: 2019-03-21 Impact factor: 4.452
Authors: Margaret L McNeely; Christopher Sellar; Tanya Williamson; Melissa Shea-Budgell; Anil Abraham Joy; Harold Y Lau; Jacob C Easaw; Albert D Murtha; Jeffrey Vallance; Kerry Courneya; John R Mackey; Matthew Parliament; Nicole Culos-Reed Journal: BMJ Open Date: 2019-09-13 Impact factor: 2.692
Authors: Hao Luo; Daniel A Galvão; Robert U Newton; Ciaran M Fairman; Dennis R Taaffe Journal: Integr Cancer Ther Date: 2019 Jan-Dec Impact factor: 3.279